Coincidentally, the majority of SW480 cells, the non-metastatic precursor cells of SW620, have the CD44+CD133− surface marker, therefore, CD44+ and CD133− are not the only determinants of CSCs for these cancer cells. This evidence concerns the gene CD44 and cancer.